Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. Issue 1 (29th November 2021)

• Record Type: Journal Article
• Authors: Chen, Haizhang; Maul‐Pavicic, Andrea; Holzer, Martin; Huber, Magdalena; Salzer, Ulrich; Chevalier, Nina; Voll, Reinhard E; Hengel, Hartmut; Kolb, Philipp
• Is Part Of: EMBO molecular medicine. Volume 14:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-11-29
• Subjects: immune complexes -- Fc‐gamma receptors -- FcγR activation -- SLE; Molecular biology -- Periodicals; Medical genetics -- Periodicals; Pathology, Molecular -- Periodicals; 616.04205
• DOI: 10.15252/emmm.202114182
• Languages: English
• ISSNs: 1757-4676

Abstract

Abstract: Fc‐gamma receptor (FcγR) activation by soluble IgG immune complexes (sICs) represents a major mechanism of inflammation in certain autoimmune diseases such as systemic lupus erythematosus (SLE). A robust and scalable test system allowing for the detection and quantification of sIC bioactivity is missing. We developed a comprehensive reporter cell panel detecting activation of FcγRs. The reporter cell lines were integrated into an assay that enables the quantification of sIC reactivity via ELISA or a faster detection using flow cytometry. This identified FcγRIIA(H) and FcγRIIIA as the most sIC‐sensitive FcγRs in our test system. Reaching a detection limit in the very low nanomolar range, the assay proved also to be sensitive to sIC stoichiometry and size reproducing for the first time a complete Heidelberger‐Kendall curve in terms of immune receptor activation. Analyzing sera from SLE patients and mouse models of lupus and arthritis proved that sIC‐dependent FcγR activation has predictive capabilities regarding severity of SLE disease. The assay provides a sensitive and scalable tool to evaluate the size, amount, and bioactivity of sICs in all settings. Synopsis: An assay utilizing a cell‐based reporter system enables the assessment of soluble antibody‐antigen complexes regarding their bioactivity. The comprehensive assay is sensitive to features of sICs that are neglected by current methodology, making it useful in experimental as well as clinical settings. A panel of cell lines stably expressing all human FcγRs was developed. The reporter cells are sensitive only to multimeric IgG antibody‐antigen soluble immune complexes (sICs), not to dimeric antibody‐antigen complexes. Accordingly, the reporter cells show sensitivity to sIC size. The assay identifies sIC bioactivity as a biomarker of systemic lupus erythematosus (SLE) disease severity. The assay supports experimentation using relevant mouse models of autoimmune disease. Abstract : An assay utilizing a cell‐based reporter system enables the assessment of soluble antibody‐antigen complexes regarding their bioactivity. The comprehensive assay is sensitive to features of sICs that are neglected by current methodology, making it useful in experimental as well as clinical settings.